Retatrutide
Triple Agonist (Experimental)
Retatrutide
Triple Agonist (Experimental)
Select Option
$200.00 each
About Retatrutide
Retatrutide is an investigational synthetic peptide that acts as a triple agonist at the GLP-1, GIP, and glucagon receptors. It is currently the subject of active clinical research and is of interest for studies comparing single, dual, and triple incretin receptor activation on metabolic signaling. Supplied as a lyophilized powder with a batch-specific certificate of analysis. For laboratory research use only. Not for human consumption.
Research Highlights
- Triple agonist at GLP-1, GIP, and glucagon receptors
- Next-generation compound under active clinical investigation
- Useful for comparative incretin receptor research
- Lyophilized powder for stability
- Third-party tested for identity and purity
- Batch-specific COA supplied with every vial
Reconstitution & Handling
- 1Supplied as a sterile lyophilized powder in a sealed vial
- 2Reconstitute with bacteriostatic water; add solvent slowly and swirl gently — do not shake
- 3Reference concentration: 15mg vial + 1.5mL solvent yields 10mg/mL
- 4Solution should be clear and colorless once fully dissolved
- 5Store reconstituted solution refrigerated at 2–8°C and use within 28 days
- 6Record lot number and reconstitution date for research documentation
Observations Reported in Literature
- •Gastrointestinal effects (nausea, vomiting, diarrhea) are the most frequently reported in early clinical literature
- •Reduced food intake is a documented pharmacological effect in trial subjects
Summarized from published research for reference only. This product is not for human consumption.
Storage Instructions
Store lyophilized vials refrigerated. Do not freeze.
Certificate of Analysis
Every batch is independently tested for identity, purity, and potency. Contact us for COA documentation on any specific batch.
Request Lab Results